Protection against cocaine toxicity in mice by the dopamine D-3/D-2 agonist R-(+)-trans-3,4a,10b-Tetrahydro-4-propyl-2H,5H[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol[(+)-PD 128,907]

JM Witkin*, D Dijkstra, B Levant, HC Akunne, A Zapata, S Peters, HE Shannon, M Gasior

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    18 Citations (Scopus)

    Abstract

    Cocaine abuse is a public health concern with seizures and death being one consequence of overdose. In the present study, dopamine D-3/D-2 receptor agonists dose dependently and completely prevented the convulsant and lethal effects of cocaine. The D-3-preferring agonists R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol) [(+)-PD 128,907], (+)-7-hydroxy-dipropylaminotetralin, and the mixed D-3/D-2 agonists quinpirole and quinelorane were all effective against cocaine toxicity in mice. The anticonvulsant effects of these compounds occurred at doses below those that produced motor impairment as assessed in the inverted screen test. Protection against the convulsant effects of the selective dopamine uptake inhibitor 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-[3-phenyl- propyl] piperazine (GBR 12909) was also conferred by (+)-PD 128,907. The possible selectivity of the effects of (+)-PD 128,907 (3 mg/kg) for these dopaminergic compounds was demonstrated by its general lack of protective efficacy against a host of convulsants acting through other neural mechanisms [pentylenetetrazol, (+)-bicuculline, and picrotoxin, 4-aminopyridine, and t-butylbiclyclophosphoorothionate, N-methyl-D-aspartate, kainate, pilocarpine, nicotine, strychnine, aminophylline, threshold electric shock, and 6-Hz electrical stimulation]. Direct and correlational evidence suggests that these effects were mediated by D-3 receptors. Protection was stereospecific and reversible by an antagonist of D-3 receptors [3-{4[1-(4-{2[4-(3-diethyamino-propoxy)-phenyl]benzoimidazol-1-yl}-butyl)-1H-benzoimidazol-2-yl]-phenoxy}propyl)-diethyl-amine; PD 58491] but not D-2 receptors [3[[4-(4-chlorophenyl)-4hydroxypipeidin-1-yl]methyl-1H-indole; L-741,626]. Anticonvulsant potencies were positively associated with potencies in a functional assay of D-3 but not D-2 receptor function. Together, these findings suggest that the prevention of cocaine convulsions and lethality by (+)-PD 128,907 may be due to D-3 receptor-mediated events.

    Original languageEnglish
    Pages (from-to)957-964
    Number of pages8
    JournalJournal of Pharmacology and Experimental Therapeutics
    Volume308
    Issue number3
    DOIs
    Publication statusPublished - 1-Mar-2004

    Keywords

    • D-3 RECEPTOR LIGANDS
    • FUNCTIONAL-CHARACTERIZATION
    • MAXIMAL ELECTROSHOCK
    • ANTICONVULSANT DRUGS
    • INDUCED SEIZURES
    • RAT
    • D3
    • PHARMACOLOGY
    • ANTAGONIST
    • IDENTIFICATION

    Fingerprint

    Dive into the research topics of 'Protection against cocaine toxicity in mice by the dopamine D-3/D-2 agonist R-(+)-trans-3,4a,10b-Tetrahydro-4-propyl-2H,5H[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol[(+)-PD 128,907]'. Together they form a unique fingerprint.

    Cite this